Test ID: MSH6M
MSH6 Mutation Screen, Blood
Method Description
Describes how the test is performed and provides a method-specific reference
DNA sequence analysis is performed to test for the presence of a mutation in all 10 exons of the MSH6 gene. Additionally, gene dosage analysis (MLPA) is used to test for the presence of large deletions and duplications in the MSH6 gene (all exons) and the TACSTD1/EPCAM gene (exons 3 and 8, 2 probes in 3-prime UTR, 1 probe 3kb downstream of TACSTD1/EPCAM, and 1 probe 2.5 kb upstream of MSH2).(Baudhuin LM, Mai M, French AJ, et al: Analysis of hMLH1 and hMSH2 gene dosage alterations in hereditary nonpolyposis colorectal cancer patients by novel methods. J Mol Diagn 2005 May;7[2]:226-2235; Casey G, Lindor NM, Papadopoulos N, et al: Conversion analysis for mutation detection in MLH1 and MSH2 in patients with colorectal cancer. JAMA 2005;293[7]:799-809)
Day(s) and Time(s) Test Performed
Outlines the days and times the test is performed. This field reflects the day and time the sample must be in the testing laboratory to begin the testing process and includes any specimen preparation and processing time required before the test is performed. Some tests are listed as continuously performed, which means assays are performed several times during the day.
Friday; 10 a.m.


